Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States,

MAJOR ARTICLE Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States, 2001 2004 Rachel J. Gorwitz, 1 Deanna Kruszon-Moran, 2 Sigrid K. McAllister, 1 Geraldine McQuillan, 2 Linda K. McDougal, 1 Gregory E. Fosheim, 1 Bette J. Jensen, 1 George Killgore, 1 Fred C. Tenover, 1 and Matthew J. Kuehnert 1 1 National Center for Preparedness, Detection, and Control of Infectious Diseases and 2 National Center for Health Statistics, Centers for Disease Control and Prevention, Atlanta, Georgia (See the article by David et al., on pages 1235 43; the article by Emonts et al., on pages 1244 53; and the editorial commentary by Flynn and Cohen, on pages 1217 9.) Background. Staphylococcus aureus is a common cause of infection, particularly in persons colonized by this organism. Virulent strains of methicillin-resistant S. aureus (MRSA) have emerged in the general community. Methods. A nationally representative survey of nasal colonization with S. aureus was conducted from 2001 through 2004 as part of the National Health and Nutrition Examination Survey. MRSA isolates were identified by the oxacillin disk-diffusion method. The pulsed-field gel electrophoresis (PFGE) type was determined for all MRSA isolates. A t statistic was used to compare the prevalence of colonization across biennia and across population subgroups. Cofactors independently associated with colonization were determined with backward stepwise logistic modeling. Results. The prevalence of colonization with S. aureus decreased from 32.4% in 2001 2002 to 28.6% in 2003 2004 (P.01), whereas the prevalence of colonization with MRSA increased from 0.8% to 1.5% (P.05). Colonization with MRSA was independently associated with healthcare exposure in males and with having been born in the United States, age 60 years, diabetes, and poverty in females. In 2003 2004, a total of 19.7% (95% confidence interval, 12.4% 28.8%) of MRSA-colonized persons carried a PFGE type associated with community transmission. Conclusions. Nasal colonization with MRSA has increased in the United States, despite an overall decrease in nasal colonization with S. aureus. PFGE types associated with community transmission only partially account for the increase in MRSA colonization. Staphylococcus aureus is an important cause of skin infections and invasive diseases, such as endocarditis, pneumonia, and osteomyelitis, in healthcare and community settings [1]. Methicillin-resistant S. aureus (MRSA) isolates are resistant to all currently Received 25 May 2007; accepted 28 September 2007; electronically published 28 March 2008. Presented in part: National Foundation for Infectious Diseases 2007 Annual Conference on Antimicrobial Resistance, Bethesda, Maryland 25 27 June 2007 (abstract S1). Potential conflicts of interest: None reported. Financial support: Office of Antimicrobial Resistance, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention. Reprints or correspondence: Rachel Gorwitz, MD, MPH, Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, MS A35, Atlanta, GA 30333 (rgorwitz@cdc.gov). The Journal of Infectious Diseases 2008; 197:1226 34 This article is in the public domain, and no copyright is claimed. 0022-1899/2008/19708-0004 DOI: 10.1086/533494 available -lactam antimicrobial agents, including -lactamase stable penicillins and cephalosporins, and have been recognized as a source of healthcareassociated infections since the 1960s [2]. More recently, distinct strains of MRSA have emerged as a cause of skin abscesses and invasive, life-threatening infections among previously healthy persons in the community [3, 4]. These epidemic strains were initially characterized by a lack of association with a healthcare setting, resistance to a limited number of non- -lactam agents, presence of genes for the Panton-Valentine leukocidin (PVL) toxin, presence of staphylococcal cassette chromosome mec (SCCmec) type IV and, in the United States, pulsed-field gel electrophoresis (PFGE) types USA300 and USA400 [5]. However, these strains are now also transmitted in healthcare settings [6 9] and demonstrate emerging resistance to non -lactam agents [10]. 1226 JID 2008:197 (1 May) Gorwitz et al.

S. aureus may colonize the anterior nares and other body sites [11]. Colonization is a strong risk factor for subsequent infection, although most persons colonized with the organism do not develop clinical disease [12]. Colonization with MRSA, in particular with PFGE type USA300, may be associated with an increased risk of subsequent infection, compared with colonization with methicillin-susceptible S. aureus (MSSA) [13, 14]. The first national population-based prevalence survey of nasal colonization with S. aureus was conducted in 2001 and 2002, and it showed a measurable prevalence of colonization with MRSA in the community [15]. The objectives of the current study were to assess national changes in the overall prevalence of nasal colonization with S. aureus and with MRSA specifically and to describe the evolving epidemiology of nasal colonization with S. aureus. METHODS Survey design and collection of data. The National Health and Nutrition Examination Survey (NHANES) is administered to a nationally representative sample of the civilian, noninstitutionalized US population selected on the basis of a stratified, multistage, probability cluster design. NHANES has been conducted continuously since 1999 and was conducted periodically before then. Data are collected through household interviews, standardized physical exams, and the collection of biological samples at mobile examination centers. A nationally representative sample is selected each year, but data are released in 2-year cycles to protect confidentiality and to increase statistical reliability. NHANES is reviewed and approved annually by an institutional review board. Informed consent is obtained from subjects or their parents or guardians. Descriptions of the survey design and sampling methods have been published elsewhere [16]. To ensure adequate sample size, the current NHANES oversamples low-income persons, adolescents aged 12 through 19 years, persons aged 60 years and older, non-hispanic black persons, and Mexican Americans. Weights were calculated for the NHANES sample to account for the unequal probabilities of selection, to adjust for nonresponse to the survey interview or examination, and to post-stratify on the basis of the Census Bureau estimates of the US population [17, 18]. Testing for nasal carriage of S. aureus was completed for all participants aged 1 year for the years 2001 through 2004. Race and ethnicity were defined by self report and classified as non- Hispanic white, non-hispanic black, or Mexican American. Persons who were not classified in one of these groups were included in the category other and were only included in analyses when all racial ethnic groups were combined. The poverty index was calculated by dividing the total family income by the US poverty threshold, adjusted for family size. Healthcare exposure was defined as an overnight stay in either an acute care or a long-term healthcare facility during the 12 months before participation in the survey. Other cofactors examined for their association with nasal carriage included sex, age (1 5 years, 6 11 years, 12 19 years, 20 39 years, 40 59 years, or 60 years), place of birth (inside or outside the United States), educational level (high school diploma or less than high school education), history of diabetes diagnosed by a health professional, and body mass index ([BMI] normal, 18.5 24.9; overweight, 25 29.9; obese 30). Educational level and BMI were analyzed only for participants older than 19 years. All statistical procedures were conducted using SUDAAN (version 9.0.1; Research Triangle Institute), a family of statistical procedures for analysis of data from complex sample surveys [19]. Estimates of the prevalence of colonization with S. aureus and MRSA were weighted to represent the US population; 95% confidence intervals (CIs) were calculated by use of an exact binomial method [20]. Standard errors were calculated by use of the Taylor series linearization method to account for the complex sample design [19]. Estimates with relative SE 30% or 12 degrees of freedom did not meet standards of reliability or precision and are indicated in the tables. The estimated total numbers of persons colonized and the corresponding confidence intervals were calculated by multiplying weighted prevalence estimates by the noninstitutionalized US population at the midpoint of each survey cycle (2001 2002 and 2003 2004), as determined by the US Census Bureau Current Population Survey [21]. Data from 2001 through 2004 were combined to provide more reliable estimates of the prevalence of colonization and to increase the study s power to detect statistically significant differences. The prevalence of colonization was also determined for each survey cycle separately, to compare prevalence between the 2 time periods. A t statistic from a linear contrast procedure was used to compare prevalence between survey cycles and between levels of a given cofactor. When the prevalence of S. aureus colonization and the prevalence of MRSA colonization were compared across population subgroups, estimates were standardized by the direct method to the age distribution of the 2000 US population for the 6 age groups used in the analyses. For the primary outcome of overall prevalence of colonization with S. aureus and MRSA in NHANES 2001 2002, compared with 2003 2004, P values.05 were considered significant. To adjust for multiple subgroup comparisons, P values.01 were considered significant for all other comparisons. A backward stepwise logistic modeling procedure in SUDAAN was used to identify cofactors that were independently associated with colonization with S. aureus or MRSA. Cofactors with a Satterthwaite adjusted F statistic P.05 were considered significant. For all multivariable models, data from 2001 through 2004 were included and survey cycle was included as a variable. Because some cofactors were measured only for adults, models for colonization with S. aureus and MRSA were initially created sepa- Changes in Prevalence of S. aureus Nasal Colonization JID 2008:197 (1 May) 1227

rately for children and adults and subsequently combined if none of the adult-specific variables were significantly associated with colonization. Interactions between each cofactor and age, sex, race and ethnicity, and survey cycle were examined. Because the associations between a number of cofactors and colonization varied by sex, models were stratified by sex to control for these interactions. Final models included race and ethnicity, age group, and survey cycle, along with all other cofactors significantly associated with colonization in either males or females in the relevant age cohort ( 20 years or 20 years for S. aureus; all ages 1 year for MRSA). Laboratory methods. Nasal swab samples were collected from both anterior nares using a Culturette swab (BBL Microbiology Systems; Becton Dickinson). Culturette swabs were plated on mannitol salt agar (BBL Microbiology Systems). Each distinctive morphotype of mannitol-fermenting colony was selected from a mannitol salt agar plate and subcultured on a trypticase soy agar plate containing 5% sheep blood (BBL Microbiology Systems). Plates were incubated at 35 C. Isolates were identified as S. aureus by morphology, latex agglutination test (Remel), and tube coagulase test (Becton Dickinson). S. aureus isolates were screened for oxacillin resistance by use of the disk-diffusion method [22]. Cultures grown overnight on trypticase soy agar plates containing 5% sheep blood were suspended in Mueller-Hinton broth to the turbidity of a 0.5 McFarland standard and plated on Mueller-Hinton agar, and a 1- g oxacillin disk was placed in the inoculum. Inhibition zone diameters were measured and recorded after 24 h of incubation at 35 C (zones were interpreted as follows: susceptible, 13 mm; intermediate, 11 12 mm; and resistant, 10 mm). Isolates that were shown by disk diffusion to be resistant to oxacillin (i.e., MRSA) and every tenth isolate shown to be susceptible to oxacillin (i.e., MSSA) were selected and saved for additional testing, including polymerase chain reaction (PCR) assays for the genes that encode PVL and SCCmec types I-IV [23, 24]. Strain typing was performed using PFGE with SmaI. The PFGE patterns were analyzed with Bionumerics (Applied Maths), and isolates were grouped into PFGE types by use of Dice coefficients and 80% relatedness [5]. RESULTS In NHANES 2003 2004, a total of 9645 persons aged 1 year were selected and interviewed; of these, 9179 (95.2%) were examined, and 9004 (98.1%) of the persons examined had nasal cultures performed. Similarly, in NHANES 2001 2002, a total of 10,470 persons aged 1 year were selected and interviewed, 9929 (94.8%) of these were examined, and 9622 (96.9%) of those examined had cultures performed. In NHANES 2003 2004, a total of 2442 of the 9004 samples were culture-positive for S. aureus, corresponding to a weighted prevalence of 28.6% (95% CI, 27.2% 30.0%) or 78.9 million persons (95% CI, 75.0 82.9 million persons) colonized with S. aureus in the US population. The prevalence of nasal colonization with S. aureus decreased, compared to 2001 2002, when the prevalence was 32.4% (95% CI, 30.8% 34.0%) or 89.4 million persons (95% CI, 85.2 93.8 million persons) (P.01). Age-standardized and age-specific estimates of colonization with S. aureus from NHANES 2001 2002 and 2003 2004 are displayed in table 1. In both surveys, colonization with S. aureus was most common in persons aged 20 years and non-hispanic white persons, compared with other age groups and other racial and ethnic groups (P.001). In 2003 2004 only, Mexican Americans were significantly more likely to be colonized than non-hispanic blacks (P.001).In2001 2002 only, males were significantly more likely to be colonized than females (P.001). When prevalence was compared across surveys, significant decreases in nasal colonization with S. aureus occurred in males (P.01) and in adults aged 60 years (P.01), as well as in the population overall (P.01). Age-specific and age-standardized estimates of S. aureus colonization for all 4 years combined (2001 2004) are displayed in table 2. Colonization with S. aureus was significantly more common among males, compared with females (P.001), among non-hispanic whites and Mexican Americans, compared with non-hispanic blacks (P.001 and P.01, respectively), and among persons aged 20 years, compared with older persons (P.001). Independent risk factors for S. aureus carriage among adults were different for men and women (table 3). For both men and women, S. aureus carriage was associated with non-hispanic white ethnicity and race, compared with non-hispanic black ethnicity and race (P.001, men; P.01, women), and with obesity, compared with normal and overweight body mass index combined (P.01, men; P.05, women). For women, foreign birth was negatively associated with colonization by S. aureus (P.05). For men, colonization with S. aureus was also associated with younger age (P.001, for comparison of ages 20 39 years and ages 60 years) and Mexican American ethnicity, compared with non-hispanic black ethnicity and race (P.05). Colonization with S. aureus among men also decreased from NHANES 2001 2002 to 2003 2004 (P.01). Independent risk factors for colonization with S. aureus in children (i.e., aged 20 years) were also analyzed separately for males and females (table 3). Among both male and female children, those aged 6 11 years and 12 19 years were significantly more likely to be colonized than those aged 1 5 years. Non- Hispanic white and Mexican American race and ethnicity, compared with non-hispanic black race and ethnicity, were associated with S. aureus colonization for male children only (P.001 and P.01, respectively). The prevalence of colonization with MRSA in 2003 2004 was 1.5% (95% CI, 1.2% 1.8%), or 4.1 million persons (95% CI, 3.3 5.1 million persons) in the US population. This represented 1228 JID 2008:197 (1 May) Gorwitz et al.

Table 1. Prevalence of nasal colonization with Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), by demographic characteristics National Health and Nutrition Examination Survey, 2001 2002 and 2003 2004. Prevalence of nasal colonization, % (95% CI) Subjects tested, no. S. aureus MRSA Characteristic 2001 2002 2003 2004 2001 2002 2003 2004 2001 2002 2003 2004 All participants a 9622 9004 32.3 (30.8 33.8) 28.7 (27.3 30.1) b 0.9 (0.5 1.4) 1.5 (1.2 1.8) c Sex a Male 4685 4413 36.6 (34.0 39.3) d 30.6 (28.6 32.7) b 0.5 (0.3 0.9) e 1.4 (1.1 1.9) b Female 4937 4591 28.1 (26.5 29.8) 26.7 (24.7 28.7) 1.1 (0.6 1.9) 1.6 (1.1 2.1) Ethnicity and race a Non-Hispanic white 3990 3659 33.3 (31.7 34.9) d 30.7 (28.6 32.8) d 0.9 (0.5 1.5) 1.6 (1.3 2.1) Non-Hispanic black f 2395 2424 25.8 (23.4 28.4) 22.0 (19.7 24.4) 1.1 (0.6 1.9) 1.6 (1.2 2.1) Mexican American 2417 2237 29.0 (26.6 31.6) 26.0 (23.7 28.4) d 0.5 (0.3 0.9) 1.1 (0.4 2.2) g Age 1 19 years f 4772 4338 36.9 (34.8 39.1) 34.6 (31.9 37.3) 0.6 (0.1 1.5) g 1.3 (0.8 1.9) 20 59 years 3290 2945 31.4 (29.5 33.4) d 27.4 (25.2 29.7) d 0.6 (0.3 1.2) g 1.1 (0.7 1.7) 60 years 1560 1721 27.7 (25.0 30.6) d 22.7 (20.8 24.7) b,d 2.2 (1.2 3.6) 3.1 (2.1 4.4) a Estimates standardized to the age distribution of the 2000 US population. b P.01 across surveys (2001 2002 vs. 2003 2004; this cutoff is reported for all comparisons). c P.05 across surveys (2001 2002 vs. 2003 2004; this cutoff is reported only when analyzing all participants not stratified by sex, race, or age). d P.001, for comparison with reference group within survey (2001 2002 or 2003 2004). e P.01, for comparison with reference group within survey (2001 2002 or 2003 2004). f Reference group. g Estimate unstable because relative SE 30. an increase in the prevalence of colonization with MRSA from 0.8% (95% CI, 0.5% 1.4%) or 2.3 million persons (95% CI, 1.3 3.8 million persons) in 2001 2002 (P.05). The prevalence of colonization with MRSA increased among males (P.01) but not among females (table 1). Colonization with MRSA was significantly more prevalent among females in 2001 2002, compared with males (P.01), but this difference was not evident in 2003 2004. When data from all 4 years were combined (table 2), colonization with MRSA was significantly more common among persons aged 60 years, compared with those aged 1 19 years (P.001). The prevalence of colonization with MRSA did not vary significantly by sex, ethnicity and race, or other cofactors in univariate analysis. In a multivariable model of colonization with MRSA in adults (i.e., 20 years of age), neither BMI nor educational level variables evaluated only for adults was significantly associated with colonization. Subsequent models therefore did not include these variables and were not stratified by age. Factors significantly associated with colonization by MRSA were different for males and females (table 3). Among males, colonization with MRSA was independently associated with healthcare exposure (P.05) and was more prevalent during NHANES 2003 2004, compared with 2001 2002 (P.05), even after controlling for other possible cofactors. For females, colonization with MRSA was significantly associated with age 60 years, compared with 1 19 years (P.01), as well as diabetes (P.05) and household income below poverty level (P.05), although foreign birth (vs birth in the United States) was negatively associated with colonization by MRSA (P.001). Among the 208 persons colonized with MRSA, the largest proportion, 50.1% (95% CI, 36.8% 63.4%), carried PFGE type USA100. USA800 was the next most prevalent PFGE type, recovered from 15.8% (95% CI, 9.4% 24.4%) of persons colonized with MRSA. The prevalence and distribution of strains associated with community transmission among persons colonized with MRSA are presented in table 4. Although these data were based on a small subsample of the original NHANES population (N 101), USA800 accounted for the largest proportion of isolates recovered from persons colonized with MRSA of SCCmec type IV (33.9% of isolates [95% CI, 18.9% 51.7%]) (data not shown in table). DISCUSSION Between 2001 2002 and 2003 2004, the overall prevalence of nasal colonization with S. aureus decreased, whereas the prevalence of colonization with MRSA increased. However, without additional data points, it is impossible to determine whether these changes represent trends in the prevalence of colonization or simply short-term modulations due to sampling variability or fluctuations in unmeasured variables, such as temperature or humidity. An increase in colonization with MRSA was anticipated, due to the recent emergence of new strains of MRSA that Changes in Prevalence of S. aureus Nasal Colonization JID 2008:197 (1 May) 1229

Table 2. Prevalence of nasal colonization with Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), by demographic and clinical characteristics National Health and Nutrition Examination Survey, 2001 2004. Prevalence of colonization, % (95% CI) Characteristic Subjects tested, no. S. aureus MRSA All participants a 18,626 30.4 (29.4 31.5) 1.2 (0.9 1.5) Sex a Male 9098 33.5 (31.8 35.2) b 1.0 (0.7 1.3) Female 9528 27.4 (26.1 28.7) 1.4 (1.0 1.8) Ethnicity and race a Non-Hispanic white 7649 31.9 (30.6 33.3) b 1.3 (1.0 1.6) Non-Hispanic black c 4819 23.8 (22.2 25.5) 1.4 (1.0 1.8) Mexican American 4654 27.4 (25.5 29.3) d 0.8 (0.4 1.4) Age group 1 19 years c 9110 35.7 (34.0 37.5) 0.9 (0.6 1.4) 20 59 years 6235 29.4 (27.9 30.9) b 0.9 (0.6 1.2) 60 years 3281 25.0 (23.4 26.8) b 2.7 (1.9 3.6) b Household income a Below poverty level 4571 29.5 (27.7 31.3) 1.7 (1.1 2.4) At or above poverty level 12,992 30.5 (29.2 31.8) 1.1 (0.8 1.4) Healthcare exposure a Any hospitalization 1679 30.6 (26.7 34.6) 2.5 (1.4 4.1) No hospitalization 16,942 30.4 (29.3 31.5) 1.1 (0.8 1.4) Birthplace a Foreign born 2811 29.6 (27.0 32.3) 0.8 (0.3 1.9) e US born 15,799 30.6 (29.5 31.8) 1.3 (1.0 1.6) Diabetes a Yes 1125 32.4 (23.8 42.0) 1.6 (0.6 3.6) e No 17,494 30.2 (29.2 31.2) 1.1 (0.9 1.5) Body mass index a,f Normal c 2877 27.1 (25.0 29.4) 1.4 (0.9 2.2) Overweight 3322 27.5 (25.6 29.4) 1.0 (0.6 1.5) Obese 2961 31.0 (28.7 33.3) 1.5 (1.0 2.2) Educational level a,f Less than high school 2817 25.3 (23.1 27.6) 1.5 (1.1 2.1) High school diploma 6684 29.0 (27.7 30.4) 1.2 (0.9 1.7) a Estimates standardized to the age distribution of the 2000 US population. b P.001. c Reference group. d P.01. e Estimate unstable because relative SE 30. f Cofactor analyzed in adults 20 years only. have been causing an increasing proportion of S. aureus infections among otherwise healthy persons in the community [4]. However, a decrease in overall nasal colonization with S. aureus was unexpected. If this represents a true trend, one potential explanation is an increase in population-level exposure to antimicrobial agents that may suppress MSSA and promote colonization with MRSA. For example, fluoroquinolone exposure has been associated with an increased risk that MRSA but not MSSA would be recovered from inpatients [25] and outpatients [26], and the prescription of fluoroquinolones in US ambulatory care settings increased significantly from 1993 1994 through 2003 2004 [27]. We identified a significant association between obesity and colonization with S. aureus in adults. This association has been described elsewhere among adult patients who underwent general, cardiothoracic, or neurologic surgery [28]. The reasons for this association are unclear, but may include physical, biochemical, or hormonal factors that predispose these individuals to colonization with S. aureus. Factors associated with colonization with MRSA included both characteristics suggesting acquisition of MRSA in a healthcare setting (such as recent healthcare exposure for males and diabetes and older age for females) [29, 30] and factors that have 1230 JID 2008:197 (1 May) Gorwitz et al.

Table 3. Multivariable models for nasal colonization with Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) National Health and Nutrition Examination Survey, 2001 2004. Colonization with S. aureus, odds ratio (95% CI) Colonization with MRSA, odds ratio (95% CI) Male Female Variable (n 4155) (n 4162) Age, children 1 5 years a 1.0 1.0 6 11 years 2.6 (2.0 3.5) b 2.5 (2.0 3.2) b 12 19 years 2.0 (1.4 2.7) b 1.5 (1.1 1.9) c Children ( 20 years) Adults ( 20 years) All ages ( 1 year) Male (n 4066) Female (n 4412) Male (n 7892) Female (n 8232) Age, adults 20 39 years a 1.0 1.0 40 59 years 0.8 (0.7 0.9) d 1.0 (0.8 1.2) 60 years 0.6 (0.4 0.7) b 0.9 (0.8 1.1) Age, all participants 1 19 years a 1.0 1.0 20 59 years 0.6 (0.2 1.5) 1.4 (0.8 2.7) 60 years 1.4 (0.6 3.0) 3.3 (1.4 7.4) d Ethnicity and race Non-Hispanic black a 1.0 1.0 1.0 1.0 1.0 1.0 Non-Hispanic white 1.6 (1.4 2.0) b 1.2 (1.0 1.5) 1.8 (1.5 2.3) b 1.4 (1.1 1.7) d 1.0 (0.6 1.7) 0.9 (0.5 1.6) Mexican American 1.3 (1.1 1.6) d 1.0 (0.8 1.2) 1.4 (1.1 1.8) c 1.2 (1.0 1.6) 0.9 (0.4 2.4) 0.5 (0.2 1.2) Household income below poverty level 0.9 (0.5 1.7) 2.0 (1.2 3.4) c Foreign born 1.1 (0.9 1.5) 0.7 (0.5 1.0) c 1.2 (0.4 3.1) 0.1 (0.0 0.4) b Hospitalization in past year 0.6 (0.3 1.3) 1.3 (0.8 2.1) 3.5 (1.2 9.9) c 1.3 (0.6 2.6) Diabetes 0.6 (0.2 1.6) 2.1 (1.0 4.1) c Obese e 1.3 (1.1 1.5) d 1.2 (1.0 1.5) c Survey cycle 2003 04 1.0 (0.8 1.2) 1.0 (0.8 1.2) 0.7 (0.6 0.9) d 0.9 (0.8 1.1) 2.3 (1.2 4.4) c 1.3 (0.7 2.3) NOTE. Bold type indicates statistical significance. CI, confidence interval. a Reference group. b P.001. c P.05. d P.01. e Reference group is non-obese (i.e., body mass index indicating the subject was normal or overweight). been associated with community transmission (poverty for females). Previous reports have also described a high prevalence of MRSA colonization and infection among persons of low socioeconomic status in the general community [31]; this may be associated with crowding, limited access to healthcare, or barriers to maintaining adequate hygiene. It is not clear why foreign birth was associated with a decreased risk of colonization with MRSA among females, but this may relate to differences in the amount and type of antimicrobial exposure between immigrant and nonimmigrant populations [32 35]. USA100, a frequent cause of healthcare-associated MRSA infections in the United States [5], and USA800, most commonly described as a source of infection among hospitalized children [36], were the most prevalent PFGE types identified in isolates from persons colonized with MRSA. This suggests that most of these colonized persons in the United States acquired MRSA in a healthcare setting. Although SCCmec type IV is a commonly described characteristic of community-associated MRSA strains such as USA300 and USA400, it is not exclusive to these PFGE types [5]. For example, MRSA of PFGE type USA800 accounted for a large proportion of SCCmec type IV isolates in this study. The proportion of persons colonized with MRSA who carried PFGE type USA300 or USA400 was 19.7% (95% CI, 12.4% 28.8%) in 2003 2004, compared with 8.1% (95% CI, 1.1% 25.3%) in 2001 2002. However, this difference was not statistically significant, and the prevalence estimate for 2001 2002 was unstable. Further surveillance will be required to determine whether colonization with these strains is becoming more prevalent. If so, the implications for morbidity and mortality due to staphylococcal infection are uncertain. However, the apparent increase in the virulence and transmissibility of MRSA strains USA300 and USA400 is cause for concern [4, 37 40]. Not surprisingly, PFGE types USA300 and USA400 and the presence of PVL genes were negatively Changes in Prevalence of S. aureus Nasal Colonization JID 2008:197 (1 May) 1231

Table 4. Prevalence of particular traits among methicillin-resistant Staphylococcus aureus (MRSA) isolates recovered from MRSA-colonized persons, by study variable National Health and Nutrition Examination Survey, 2001 2004. Isolates, no. (% [95% CI]) Variable Subjects colonized with MRSA, no. PVL genes present SCCmec IV present USA300 or USA400 All participants 208 31 (14.4 [8.8 21.7]) 101 (44.7 [32.2 57.6]) 37 (15.6 [9.9 22.9]) Sex Male 93 14 (13.9 [6.5 24.9) a ) 50 (46.2 [28.1 65.0]) 15 (14.1 [6.7 25.1) a ) Female b 115 17 (14.7 [7.3 25.5]) 51 (43.7 [30.7 57.3]) 22 (16.6 [9.0 27.1]) Ethnicity and race c Non-Hispanic white 102 15 (14.5 [8.2 23.1]) 36 (39.8 [25.5 55.5) d ) 17 (15.3 [8.6 24.2]) Non Hispanic black b 64 11 (15.8 [5.8 31.7) a,e ) 49 (74.7 [60.3 86.0) e ) 14 (19.9 [8.4 36.9) a,e ) Age group 1 19 years b 79 14 (15.2 [6.7 27.9) a,e ) 55 (65.3 [37.5 87.0) e ) 17 (16.5 [7.8 29.0) a,e ) 20 59 years 51 14 (23.5 [12.3 38.3) e ) 35 (63.4 [45.1 79.3) e ) 15 (24.4 [13.3 38.8) e ) 60 years 78 3 (3.0 [0.2 12.6) a ) 11 (9.7 [3.5 20.4) a,f ) 5 (4.6 [0.7 14.1) a ) Healthcare exposure Any hospitalization 51 3 (4.6 [0.7 14.6) a,d,e ) 16 (28.8 [13.9 48.0) e ) 4 (4.9 [0.8 14.7) a,d,e ) No hospitalization b 157 28 (16.7 [9.9 25.6]) 85 (48.4 [34.9 62.2]) 33 (18.2 [11.2 27.2]) Survey 2001 2002 b 75 6 (7.9 [1.1 25.2) a,e ) 37 (47.2 [22.8 72.6) e ) 7 (8.1 [1.1 25.3) a,e ) 2003 2004 133 25 (17.9 [10.9 26.9]) 64 (43.3 [30.2 57.2]) 30 (19.7 [12.4 28.8]) NOTE. Weighted estimates and 95% confidence intervals (CIs) are presented along with the actual numbers of subjects so that the reliability of the estimates can be evaluated and interpreted appropriately. Estimates are based on small sample sizes and small numbers of subjects with a given characteristic. CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus; PVL, Panton-Valentine leukocidin; SCCmec, staphylococcal cassette chromosome mec. a Relative SE 30. b Reference group. c Categories for Mexican American and Other ethnicity are not provided because of small sample sizes but are included in totals. d P.01. e Degrees of freedom 12. f P.001. associated with recent hospitalization. This may change as these PFGE types become more established in healthcare facilities. Unlike some other recent reports of colonization with MRSA [41 43], and in contrast to reports of increasing incidence of MRSA infection in healthcare settings and the general community [4, 44], the prevalence of colonization with MRSA remained fairly low in this representative sample of the noninstitutionalized US population. The small proportion of persons carrying MRSA PFGE types USA300 or USA400 among all persons colonized with S. aureus, in contrast to the large proportion of community-associated S. aureus infections caused by MRSA PFGE type USA300 in some reports [4], suggests that strains of this PFGE type are more virulent than other S. aureus strains and therefore more likely to cause infection in those persons who do become colonized [13]. It is also possible, although unproven, that the new epidemic MRSA strains preferentially colonize sites other than the nares. Although the anterior nares are considered the primary site of S. aureus colonization, based on historical data, colonization can occur at other sites, such as the skin, throat, vagina, or gastrointestinal tract [45 47]. To test the hypothesis that certain strains of MRSA are more likely to colonize sites other than the nares, culture samples of colonizing organisms must be obtained from multiple body sites on colonized persons. Few data are available to test this hypothesis directly [48]. However, recent sequencing of the USA300 genome identified a mobile genetic element, called the arginine catabolic mobile element, which was not detected in other S. aureus strains but was prevalent among S. epidermidis, which commonly colonizes the skin [49]. The authors hypothesized that the arginine catabolic mobile element enhances the capacity of USA300 to survive on human skin by maintaining ph homeostasis in an acidic environment. The results of our study have implications for infection control and clinical management strategies that are impacted by the prevalence of colonization with MRSA. The increasing prevalence of MRSA as a cause of community-associated skin infection [4] has led to the assumption that colonization with MRSA must be widespread in the general community. This could make it impractical to maintain special infection control measures for hospitalized patients with MRSA infection. In addition, it would indicate a need to modify prophylaxis for surgical site infections and other wound infections to provide MRSA coverage, because such prophylaxis is primarily selected to provide coverage 1232 JID 2008:197 (1 May) Gorwitz et al.

against infection with a patient s endogenous flora. It is important to monitor the population-specific prevalence of colonization and infection with MRSA on a local level to best inform both infection control strategies and selection of antimicrobial prophylaxis. However, our data suggest that modification of current measures is not universally warranted at this time. This analysis was subject to limitations. First, the survey design was cross-sectional. Therefore, persons who were only intermittently colonized may not have been detected. To the extent that some organism characteristics correlate with intermittent or prolonged colonization, the frequency of colonization with organisms possessing these characteristics would thus have been underestimated. Some variables of interest, such as recent exposure to antimicrobial agents, were not available for analysis. In addition, because the NHANES sample is not selected to be nationally representative on a monthly or quarterly basis, seasonal variation in S. aureus colonization could not be explored. Finally, many estimates did not meet standards of reliability or precision when the prevalence of colonization with particular MRSA isolate types was examined. These results should, therefore, be interpreted with caution. In conclusion, the prevalence of nasal colonization with MRSA increased in the United States between 2001 2002 and 2003 2004. Although the prevalence of colonization with MRSA remains low, this increase is remarkable, given that the overall prevalence of colonization with S. aureus decreased over the same time period. Reasons for these changes are unclear, and additional data will be required to determine whether these changes represent ongoing trends. The epidemiology of S. aureus infection has continued to evolve, due in part to the emergence and epidemic spread of certain MRSA PFGE types, such as USA300 [4]. The spread of these PFGE types in community and healthcare settings may account for some of the increase in colonization with MRSA [9, 42, 43]. However, the relative prevalence of other MRSA PFGE types linked almost exclusively to transmission in healthcare settings suggests that MRSA acquisition in the healthcare environment remains an important source of colonization with MRSA in the community. Additional studies are needed to determine whether available intervention strategies, such as decolonization, are warranted under certain circumstances; to determine whether these interventions will have an impact on the risk of subsequent infection; to explore the role of antimicrobial exposure in colonization with S. aureus and/or MRSA; and to determine whether PFGE types USA300 and USA400 preferentially colonize sites other than the nares. Although the prevalence of colonization with MRSA is increasing, our data suggest that surveillance cultures not directed at any specific high-risk population in the community setting are unlikely to identify a substantial proportion of persons colonized with MRSA at this time. Acknowledgments We would like to thank Roberta Carey, PhD; Brandi Limbago, PhD; David Lonsway, MMS; L. Clifford McDonald, MD; and Jean Patel, PhD, at the Centers for Disease Control and Prevention, Atlanta, Georgia, for their input on the analysis and interpretation of these data. References 1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520 32. 2. Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med 1968; 279:441 8. 3. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436 44. 4. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666 74. 5. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113 20. 6. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004; 39:1460 6. 7. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005; 33:385 91. 8. Saiman L, O Keefe M, Graham PL 3rd, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37:1313 9. 9. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42:647 56. 10. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785 91. 11. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505 20. 12. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 2001; 344:11 6. 13. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971 9. 14. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315:91 6. 15. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus Nasal Colonization in the United States, 2001 2002. J Infect Dis 2006; 193:172 9. 16. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES) 1999 2002. Available at: http:// www.cdc.gov/nchs/about/major/nhanes/datalink.htm. Accessed 1 November 2006. 17. Ezzati T, Khare M. Non-response adjustment in a national health survey. 1992 Proceedings of the Survey Research Methods Section of the American Statistical Association 1993:339 344. 18. Mohadjer L, Montaquila J, Waksberg J. National Health and Nutrition Examination Survey III: weighting and examination methodology. Pre- Changes in Prevalence of S. aureus Nasal Colonization JID 2008:197 (1 May) 1233

pared for the National Center for Health Statistics. Hyattsville, MD: Westat, 1996. 19. Shah BV, Barnwell BG, Bieler GS, La Vange LM. SUDAAN Software for the statistical analysis of correlated data: user s manual, release 7.0. Research Triangle Park, North Carolina: Research Triangle Institute, 1996. 20. Korn EL, Graubard BI. Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Survey Methodology 1998; 24:193 201. 21. US Census Bureau. Current Population Survey, 2004. Available at: http://www.census.gov/cps. Accessed 24 January 2007. 22. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 14th informational supplement (M1000-S14). Wayne, PA: National Committee for Clinical Laboratory Standards, 2004. 23. Ito T, Okuma K, Ma XX, Yuzawa H, Hiramatsu K. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Resist Updat 2003; 6:41 52. 24. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289 94. 25. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003; 9:1415 22. 26. McDonald LC, Lauderdale TL, Lo HJ, Tsai JJ, Hung CC. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS 2003; 14: 473 7. 27. McCaig LF, Friedman CR. Trends in antimicrobial prescribing in ambulatory care settings in the United States, 1993 2004 [abstract P1]. In: Program and abstracts of the 2006 Annual Conference on Antimicrobial Resistance (Bethesda, MD). Bethesda, MD: National Foundation for Infectious Diseases, 2006:45. 28. Herwaldt LA, Cullen JJ, French P, et al. Preoperative risk factors for nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 2004; 25:481 4. 29. Boyce JM. Methicillin-resistant Staphylococcus aureus. Detection, epidemiology, and control measures. Infect Dis Clin North Am 1989; 3:901 13. 30. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309 17. 31. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34:425 33. 32. Cespedes A, Larson E. Knowledge, attitudes, and practices regarding antibiotic use among Latinos in the United States: review and recommendations. Am J Infect Control 2006; 34:495 502. 33. Larson EL, Dilone J, Garcia M, Smolowitz J. Factors which influence Latino community members to self-prescribe antibiotics. Nurs Res 2006; 55:94 102. 34. Mainous AG 3rd, Cheng AY, Garr RC, Tilley BC, Everett CJ, McKee MD. Nonprescribed antimicrobial drugs in Latino community, South Carolina. Emerg Infect Dis 2005; 11:883 8. 35. Mangione-Smith R, Elliott MN, Stivers T, McDonald L, Heritage J, McGlynn EA. Racial/ethnic variation in parent expectations for antibiotics: implications for public health campaigns. Pediatrics 2004; 113: e385 94. 36. Sa-Leao R, Santos Sanches I, Dias D, Peres I, Barros RM, de Lencastre H. Detection of an archaic clone of Staphylococcus aureus with low-level resistance to methicillin in a pediatric hospital in Portugal and in international samples: relics of a formerly widely disseminated strain? J Clin Microbiol 1999; 37:1913 20. 37. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillinresistant Staphylococcus aureus. Pediatrics 2005; 115:642 8. 38. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003 04 influenza season. Emerg Infect Dis 2006; 12:894 9. 39. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445 53. 40. Mongkolrattanothai K, Boyle S, Kahana MD, Daum RS. Severe Staphylococcus aureus infections caused by clonally related communityacquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37:1050 8. 41. Alfaro C, Mascher-Denen M, Fergie J, Purcell K. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children s Hospital. Pediatr Infect Dis J 2006; 25: 459 61. 42. Creech CB, 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24:617 21. 43. Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159 66. 44. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470 85. 45. Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5992 5. 46. Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard JD, Joly- Guillou ML. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27:181 4. 47. Nilsson P, Ripa T. Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol 2006; 44:3334 9. 48. Rosenthal A, White D, Churilla S, Brodie S, Katz KC. Optimal surveillance culture sites for detection of methicillin-resistant Staphylococcus aureus in newborns. J Clin Microbiol 2006; 44:4234 6. 49. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillinresistant Staphylococcus aureus. Lancet 2006; 367:731 9. 1234 JID 2008:197 (1 May) Gorwitz et al.